The third wave of COVID-19 in Pakistan was harder than the two before it. Positivity climbed, the newer variant was more aggressive and at times slipped past a PCR test, and clinicians leaned on CT scans and chest X-rays to see what the swab missed. Hospitals filled, ventilators were scarce, and the pressure reached every part of the system that keeps a theatre running — including the instruments in it.
A hard spotlight on sterilisation
When infection control is the whole conversation, the way an instrument survives sterilisation stops being a footnote. A tool that pits, loses its edge or works its joint loose after repeated autoclaving is a liability in ordinary times and a real risk in a surge. The pandemic made that concrete: the instruments people trusted were the ones that came out of the cycle the same as they went in.
Supply, when it suddenly mattered
Demand did not rise gently; it spiked, and the supply chains behind medical goods were tested at every link. For a workshop, the lesson was about dependability over cleverness — being able to hold a standard while making more, and being honest with customers about lead times instead of promising what a stretched line could not deliver.
A surge does not reward the fastest supplier. It rewards the one whose instruments come out of the autoclave unchanged.
What stayed with us
- An instrument's real test is the sterilisation cycle, not the showroom.
- Consistency under pressure matters more than peak speed.
- Clear, honest lead times are part of the product.
Looking back from the bench
The waves passed, but the way we weigh a pattern did not go back. We still ask the same question we asked before — will a person trust this in their hand — and we now ask it knowing what a bad answer costs when a hospital is full. That is not a slogan. It is just the reason every piece still gets checked by hand before it leaves.
Need an instrument like the ones we write about?
Browse the catalogue
